MetaVia Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MTVA research report →
Companywww.metaviatx.com
MetaVia Inc. , a clinical-stage biotechnology company focuses on developing and commercializing novel pharmaceuticals to treat cardiometabolic diseases. It develops DA-1241, a novel G-Protein-Coupled Receptor 119 agonist with development optionality as a standalone and/or combination therapy that is in Phase 2a clinical trial for metabolic dysfunction-associated steatohepatitis (MASH), and has completed Phase 1 clinical trial for the treatment of type 2 diabetes mellitus (T2DM); and DA-1726, a novel oxyntomodulin analogue functioning as a GLP-1 receptor and glucagon receptor dual agonist, which is in preclinical development for the treatment of obesity.
- CEO
- Hyung Heon Kim
- IPO
- 2016
- Employees
- 9
- HQ
- Cambridge, MA, US
Price Chart
Valuation
- Market Cap
- $6.36M
- P/E
- -1.07
- P/S
- 0.00
- P/B
- 1.55
- EV/EBITDA
- 0.53
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- -172.92%
- ROIC
- -149.42%
Growth & Income
- Revenue
- $0 · 0.00%
- Net Income
- $-12,973,000 · 52.98%
- EPS
- $-7.35 · 81.23%
- Op Income
- $-13,708,000
- FCF YoY
- 36.47%
Performance & Tape
- 52W High
- $19.03
- 52W Low
- $0.97
- 50D MA
- $1.39
- 200D MA
- $5.87
- Beta
- 0.58
- Avg Volume
- 1.53M
Get TickerSpark's AI analysis on MTVA
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 23, 26 | Woodworth Marshall H | other | 28,000 |
| Jan 23, 26 | Kim Hyung Heon | other | 32,000 |
| Aug 12, 25 | Woodworth Marshall H | other | 14,200 |
| Jun 30, 25 | Glickman Mark A | other | 28,147 |
| Jun 30, 25 | GROVES JASON L | other | 28,147 |
| Jun 30, 25 | Tursi James Patrick | other | 28,147 |
| Jun 30, 25 | STRICKLAND D GORDON | other | 28,147 |
| Jun 30, 25 | KOVEN ANDREW I | other | 28,147 |
| Jun 30, 25 | Salsbury Michael | other | 28,147 |
| Jun 4, 25 | Woodworth Marshall H | buy | 14,200 |
Our MTVA Coverage
We haven't published any research on MTVA yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MTVA Report →